Endo Pharmaceutical Holdings Inc. (ENDP): Today's Featured Health Care Loser
Endo Pharmaceutical Holdings (ENDP) pushed the Health Care sector lower today making it today's featured Health Care loser. The sector as a whole closed the day up 1.3%. By the end of trading, Endo Pharmaceutical Holdings fell 24 cents (-0.8%) to $29.88 on heavy volume. Throughout the day, 3.1 million shares of Endo Pharmaceutical Holdings exchanged hands as compared to its average daily volume of 1.4 million shares. The stock ranged in price between $29.75-$30.42 after having opened the day at $30.10 as compared to the previous trading day's close of $30.12. Other company's within the Health Care sector that declined today were: NPS Pharmaceuticals (NPSP), down 11.9%, ImmunoCellular Therapeutics (IMUC), down 11.9%, Urologix (ULGX), down 11.7%, and Strategic Diagnostics (SDIX), down 7.2%. Endo Health Solutions Inc. provides specialty healthcare solutions in the United States and internationally. Endo Pharmaceutical Holdings has a market cap of $3.62 billion and is part of the drugs industry. The company has a P/E ratio of 90.9, equal to the average drugs industry P/E ratio and above the S&P 500 P/E ratio of 17.7. Shares are down 10.8% year to date as of the close of trading on Thursday. Currently there are 13 analysts that rate Endo Pharmaceutical Holdings a buy, no analysts rate it a sell, and seven rate it a hold. TheStreet Ratings rates Endo Pharmaceutical Holdings as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, generally poor debt management and disappointing return on equity.
- You can view the full Endo Ratings Report.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
Latest Headlines about ENDP
-
4 Stocks Rising on Unusual Volume
03:13PM 04/17/13
-
4 Stocks Rising on Unusual Volume
03:15PM 02/25/13
-
5 Names Seeing Bullish Option Flow
12:13PM 12/20/12
-
Analysts' Actions: ADBE CLWR MSFT MU
09:45AM 12/14/12
-
Endo Health Solutions' CEO Discusses Q2 2012 Results - Earnings Call Transcript
04:01PM 08/07/12
-
7 Stocks Surging on Big Volume
01:28PM 05/29/12
-
Downgrades Roundup: SPX, Avon, Shutterfly
07:39AM 05/07/12
Latest from TheStreet Wire
-
Infosys Ltd (INFY): Today's Featured Technology Laggard
05:01PM 05/24/13
-
Williams Companies Inc (WMB): Today's Featured Basic Materials Laggard
05:01PM 05/24/13
-
Trimble Navigation Limited (TRMB): Today's Featured Electronics Laggard
05:01PM 05/24/13
-
Deere & Co (DE): Today's Featured Industrial Laggard
05:01PM 05/24/13
-
Eli Lilly And Company (LLY): Today's Featured Drugs Laggard
05:01PM 05/24/13
-
Sap AG (SAP): Today's Featured Computer Software & Services Laggard
05:01PM 05/24/13
-
Duke Energy Corporation (DUK): Today's Featured Utilities Laggard
05:01PM 05/24/13
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
